Company profile: Triangle Insights Group
1.1 - Company Overview
Company description
- Provider of strategy consulting services to life sciences organizations, guiding leaders on critical business issues with deep industry knowledge. Offerings include pricing and market access, commercial strategy and execution, R&D prioritization, commercial launch strategy, due diligence, and portfolio strategy.
Products and services
- Commercial Strategy and Execution: Architects and runs product commercialization strategies using a segmentation-driven approach, including precise targeting and segmentation, to plan and execute commercialization for life sciences organizations
- Commercial Launch Strategy: Develops a launch strategy, crafts an implementation plan, and establishes a tracking program using an implementation-focused methodology for life sciences
- Pricing and Market Access: Evaluates access and coverage using analogs and primary research across regions via a primary-research-based framework to guide market access assessments for life sciences offerings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Triangle Insights Group
Bionova Scientific
HQ: United States
Website
- Description: Provider of biologics development and manufacturing services, specializing in cell line development for new biological entities and biosimilars, upstream and downstream process development, analytical sciences, and formulation. Offers GMP manufacturing with single-use bioreactors, scale-up and tech transfer support, expertise with complex proteins and antibody drug conjugates, and regulatory compliance without licensing fees.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bionova Scientific company profile →
ClinicalRM
HQ: United States
Website
- Description: Provider of full-service contract research solutions specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs, and devices, offering a wide array of research, regulatory, and sponsor services within the U.S. to help customers get products to market faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClinicalRM company profile →
Reaction Biology
HQ: United States
Website
- Description: Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reaction Biology company profile →
Ergomed
HQ: United Kingdom
Website
- Description: Provider of specialized services to the pharmaceutical industry and the development of new drugs, operating two complementary businesses, including a well-established clinical research business providing services to the pharmaceutical and biotechnology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ergomed company profile →
DynaKin
HQ: Spain
Website
- Description: Provider of contract research services featuring a GLP biolab, model-based drug development, GCP clinical trial design and execution, and product-oriented R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DynaKin company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Triangle Insights Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Triangle Insights Group
2.2 - Growth funds investing in similar companies to Triangle Insights Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Triangle Insights Group
4.2 - Public trading comparable groups for Triangle Insights Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →